3-Fluoro-2-[(1-methylpiperidin-4-yl)methoxy]aniline, 95.0%, 1g

2-Chloro-5,8,11-trimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one, 250mg

(3R)-pyrrolidine-3-carboxylic acid hydrochloride, 95.0%, 1g

Weithals-Standflasche, m. NS-Glasstopfen, DURAN®, klar, 1000 ml, 1 Stück

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((4-methylbenzyl)selanyl)propanoic acid, 97%, 250mg

5-Bromo-2-hydrazinopyridine>96.0%(GC)(T)5g

Ethyl Palmitate>97.0%(GC)25mL

(3R)-3-(Bromomethyl)-2,3-dihydro-1,4-benzodioxine, 97%, 1g

(S)-3-Methyl-pyrrolidine hydrochloride, 97.0%, 10g

(R)-2,2-Dimethyl-1-phenylpropan-1-amine hydrochloride, 95.0%, 5g

N-(2-Trifluoromethylphenyl)-2-chloropropanamide, 95%, 2g

Cryo-Rac für Cryo-Boxen, breite Ausf., 4 x 5 Fächer, L 566 x B 140 x H 274 mm, 1 Stück

4-bromo-2H-indazol-6-amine, 97%, 1g